Abdalla A. Ammar, BCPS
Staff Affiliate - YNHHCards
About
Research
Publications
2023
971: EVALUATING APTT PROLONGATION WITH HEPARIN THROMBOPROPHYLAXIS IN UNDERWEIGHT CRITICALLY ILL PATIENTS
Kumar P, Ammar A, Dumitru R. 971: EVALUATING APTT PROLONGATION WITH HEPARIN THROMBOPROPHYLAXIS IN UNDERWEIGHT CRITICALLY ILL PATIENTS. Critical Care Medicine 2023, 52: s457-s457. DOI: 10.1097/01.ccm.0001002048.77367.bc.Peer-Reviewed Original Research1344: CONTINUOUS-INFUSION SEDATION LORAZEPAM VERSUS MIDAZOLAM IN CRITICALLY ILL PATIENTS
Ammar M, Ammar A, Owusu K, Siner J, Chess A, Johnson J. 1344: CONTINUOUS-INFUSION SEDATION LORAZEPAM VERSUS MIDAZOLAM IN CRITICALLY ILL PATIENTS. Critical Care Medicine 2023, 52: s643-s643. DOI: 10.1097/01.ccm.0001003536.79179.66.Peer-Reviewed Original Research
2022
Neuropharmacology in the Intensive Care Unit
Ammar A, Ammar M, Tesoro E. Neuropharmacology in the Intensive Care Unit. Critical Care Clinics 2022, 39: 171-213. PMID: 36333031, DOI: 10.1016/j.ccc.2022.07.007.Peer-Reviewed Original ResearchConceptsChronic medication useIntensive care unitAcute neurological injuryAcute illnessAntiseizure medicationsDrug regimensIll adultsMedication useCare unitVasoactive agentsNeurological injuryReversal agentsPharmacodynamic propertiesDrug effectsPharmacologic knowledgeCliniciansMultiple factorsAgentsOsmotherapyComorbiditiesAnalgesicsMedicationsRegimensPharmacotherapyPatients
2020
987: TRANSITIONING FROM DEXMEDETOMIDINE INFUSION WITH THE USE OF ENTERAL CLONIDINE
Cheung C, Ammar A, Rouse G, Ammar M. 987: TRANSITIONING FROM DEXMEDETOMIDINE INFUSION WITH THE USE OF ENTERAL CLONIDINE. Critical Care Medicine 2020, 48: 473-473. DOI: 10.1097/01.ccm.0000633484.12426.30.Peer-Reviewed Original Research